How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

267,327 results for

Risk Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part I: Review of Anticoagulation Agents and Clinical Considerations Full Text available with Trip Pro

Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part I: Review of Anticoagulation Agents and Clinical Considerations Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part I: Review of Anticoagulation Agents and Clinical (...) Considerations - Journal of Vascular and Interventional Radiology Email/Username: Password: Remember me Available now: Use your SIR login to access JVIR. Search Terms Search within Search Share this page Access provided by Article in Press Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part I: Review of Anticoagulation Agents and Clinical Considerations Endorsed

2019 Society of Interventional Radiology

22. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations. Full Text available with Trip Pro

Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations - Journal of Vascular and Interventional Radiology Email/Username: Password (...) : Remember me Available now: Use your SIR login to access JVIR. Search Terms Search within Search Share this page Access provided by Article in Press Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe x

2019 Society of Interventional Radiology

23. 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy

2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy | Heart Rhythm Society Utility Menu Main navigation Search Main Menu Breadcrumb to access the pocket guide. Ablation Atrial Arrhythmias Clinical Ep Device Therapy Heart Failure / CRT Pediatric Training Ventricular Arrhythmias Downloads Improving the Care

2019 Heart Rhythm Society

24. Cyanobacteria and Drinking Water: Occurrence, Risks, Management and Knowledge Gaps for Public Health

during bloom season limits the ability to communicate the relative risk of harm to the public from cyanoblooms, and encourage citizen engagement in mitigation meaures. 49 Photo credit: Conrad Kuiper via PhotoPinNational Collaborating Centre for Environmental Health 12 SCAN OF PROVINCIAL AND TERRITORIAL APPROACHES TO MANAGING CYANOBACTERIAL RISKS TO DRINKING WATER All provinces have adopted the Health Canada Guidelines for drinking water into provincial guidance, although monitoring for cyanotoxins (...) Cyanobacteria and Drinking Water: Occurrence, Risks, Management and Knowledge Gaps for Public Health CYANOBACTERIA AND DRINKING WATER: OCCURRENCE, RISKS, MANAGEMENT AND KNOWLEDGE GAPS FOR PUBLIC HEALTH MARCH 2019 Prepared by: Juliette O’Keeffe National Collaborating Centre for Environmental Health Photo credit: Ake via rawpixelNational Collaborating Centre for Environmental Health 1 INTRODUCTION With warming temperatures due to climate change and increased nutrient loads to freshwater systems

2019 National Collaborating Centre for Environmental Health

25. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women’s Sexual Health

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women’s Sexual Health CONSENSUS RECOMMENDATIONS Managementofgenitourinarysyndromeofmenopauseinwomenwith orathighriskforbreastcancer:consensusrecommendationsfromThe North American Menopause Society and The International Society for the Study of Women’s Sexual Health Stephanie S (...) forthese women. The Expert Consensus Panel iscomprised of a diverse group of 16 multidisciplinary experts wellrespectedintheirfields.Thepanelistsindividuallyconductedanevidence-basedreviewoftheliteratureintheir respective areas of expertise. They then met to discuss the latest treatment options for genitourinary syndrome of menopause (GSM) in survivors of breast cancer and review management strategies for GSM in women with or at high risk for breast cancer, using a modified Delphi method

2019 The North American Menopause Society

26. Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer

Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – European Society of Gastrointestinal Endoscopy (ESGE) +49-89-9077936-11 Menu DOI https://doi.org/10.1055/a-1016-4977 | Endoscopy 2019; 51:1082–1093 Published online: 9.10.2019 © Georg Thieme Verlag KG Stuttgart · New York Explore the ESGE website Menu Contact us +49

2019 European Society of Gastrointestinal Endoscopy

27. Management of patients with increased risk for familial pancreatic cancer

Management of patients with increased risk for familial pancreatic cancer 1 Goggins M, et al. Gut 2019;0:1–11. doi:10.1136/gutjnl-2019-319352 Guidelines Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium Michael Goggins , 1 Kasper Alexander Overbeek , 2 Randall Brand, 3 Sapna Syngal, 4 Marco Del Chiaro, 5 Detlef K Bartsch, 6 Claudio Bassi, 7 Alfredo Carrato, 8 James Farrell (...) and permissions. Published by BMJ. AbsTrACT background and aim The International Cancer of the Pancreas Screening Consortium met in 2018 to update its consensus recommendations for the management of individuals with increased risk of pancreatic cancer based on family history or germline mutation status (high- risk individuals). Methods A modified Delphi approach was employed to reach consensus among a multidisciplinary group of experts who voted on consensus statements. Consensus was considered reached if =75

2019 British Society of Gastroenterology

28. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors Full Text available with Trip Pro

2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors 2019 ASCCP Risk-Based Management Consensus Guidelines for Ab... : Journal of Lower Genital Tract Disease ')} You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page. Your account has been temporarily locked Your account has been temporarily locked due to incorrect sign in attempts and will be automatically (...) surveillance for prior abnormal screening results. The 2012 consensus guidelines were the first to be based on the principle of equal management for equal risk, specifically, the risk of a patient developing cervical cancer, estimated by the surrogate end point of the 5-year risk of cervical intraepithelial neoplasia (CIN) grade 3 (CIN 3) or more severe diagnoses (CIN 3+), regardless of which test combinations yielded this risk level. Introduction of risk-based guidelines in 2012 was a conceptual

2019 American Society for Clinical Pathology

29. Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women

Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women - ACOG Menu ▼ Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous (...) Women Page Navigation ▼ Share: Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women This Practice Advisory has been endorsed by the Society for Maternal-Fetal Medicine. A randomized controlled trial comparing elective induction of labor at 39 weeks gestation with expectant management among low-risk nulliparous women was published in the on August 8, 2018 (1). The study was a large unmasked

2018 American College of Obstetricians and Gynecologists

30. Canadian Cardiovascular Society Guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery

Canadian Cardiovascular Society Guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery Society Guidelines Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery Emmanuelle Duceppe, MD, a,b,c Joel Parlow, MD, MSc (Co-chair), d Paul MacDonald, MD, e Kristin Lyons, MDCM, f Michael McMullen, MD, d Sadeesh Srinathan, MD, MSc, g Michelle Graham, MD, h Vikas (...) Society for Vascular Surgery; members are listed in Appendix 1. Guidelines Development The primary panel established the scope of the guidelines (ie, 4 themes: preoperative cardiac risk assessment, perioper- ative cardiac risk modi?cation, monitoring for perioperative cardiac events, and management of perioperative cardiac complications), identi?ed topics and working groups, searched the literature, developed the summary of ?ndings and GRADE quality assessment tables, voted on the recom- mendations

2017 CPG Infobase

31. Management of term infants at increased risk for early onset bacterial sepsis

Management of term infants at increased risk for early onset bacterial sepsis Early-onset neonatal bacterial sepsis (EOS) is sepsis occurring within the first seven days of life. This statement provides updated recommendations for the care of term (≥37 weeks’ gestational age) newborns at risk of EOS, during the first 24 h of life. Maternal group B streptococcal (GBS) colonization in the current pregnancy, GBS bacteruria, a previous infant with invasive GBS disease, prolonged rupture (...) . The management of well-appearing, at-risk term infants depends on the number of risk factors (including maternal GBS colonization) and whether maternal intrapartum antibiotic prophylaxis for GBS was used. In some cases, management should be individualized. Careful assessment and observation of these at-risk infants are a fundamental component of appropriate care. Key Words: Chorioamnionitis; Early-onset sepsis; Group B streptococcus; Newborn

2017 Canadian Paediatric Society

32. Risk Communication and Community Engagement (RCCE) Action Plan Guidance COVID-19 Preparedness and Response

Risk Communication and Community Engagement (RCCE) Action Plan Guidance COVID-19 Preparedness and Response Risk Communication and Community Engagement (RCCE) Action Plan Guidance COVID-19 Preparedness and Response WHO Regional websites / / Risk Communication and Community Engagement (RCCE) Action Plan Guidance COVID-19 Preparedness and Response Overview This tool is designed to support risk communication, community engagement staff and responders working with national health authorities

2020 WHO Coronavirus disease (COVID-19) Pandemic

33. Climate-resilient water safety plans: managing health risks associated with climate variability and change

Climate-resilient water safety plans: managing health risks associated with climate variability and change Climate-resilient water safety plans: managing health risks associated with climate variability and change JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Climate-resilient water safety plans: managing health risks associated with climate variability and change View/ Open (...) Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. Climate-resilient water safety plans: managing health risks associated with climate variability and change. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Description vi, 82 p. ISBN 9789241512794 Collections Language English Metadata Related items Showing items related by title and MeSH subject.  Assemblée mondiale de la Santé, 51 (‎ A51/40 , 1998 )‎  World Health Assembly, 51 (‎ A51/40 , 1998

2017 WHO

34. Non-Statin Therapies For LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

to the clinician-patient discus- sion and includes questions to evaluate muscle-related symptoms, step-by-step guidance in the management of statin-related muscle symptoms, and a drug comparison tool for consideration of statin characteristics and po- tential drug–drug interactions. Non-statintherapies:Currentlyavailablestrategiesand agents that are considered in this document for the management of LDL-related ASCVD risk are described in Table 4. Dietary adjuncts for lowering atherogenic cholesterol may also (...) Non-Statin Therapies For LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk EXPERT CONSENSUS DECISION PATHWAY 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways Endorsed by the National Lipid Association Writing

2017 American College of Cardiology

35. ESMO Consensus Conference on Malignant Lymphoma: Management of ?ultra-high-risk? Patients

ESMO Consensus Conference on Malignant Lymphoma: Management of ?ultra-high-risk? Patients SPECIAL ARTICLE ESMO Consensus Conference on malignant lymphoma: management of ‘ultra-high-risk’ patients M. Hutchings 1 * , M. Ladetto 2 , C. Buske 3 , P. de Nully Brown 1 , A. J. M. Ferreri 4 , M. Pfreundschuh 5† , N. Schmitz 6 , A. Sureda Balari 7 , G. van Imhoff 8 , J. Walewski 9 & the ESMO Lymphoma Consensus Conference Panel Members ‡ 1 Department of Hematology, Rigshospitalet, Copenhagen, Denmark; 2 (...) poorly to therapy and eventually die from their disease. A number of clinical and pathological factors de?ne groups of patients who are at very high risk of such treatment failure. For these ‘ultra-high-risk’ patients, there is no international consensus regarding the opti- mal management approach. In 2015, the European Society for Medical Oncology (ESMO) held a consensus conference on malignant lymphoma in order to develop recommendations on critical subjects that were dif?cult to consider in detail

2018 European Society for Medical Oncology

36. ESMO Consensus Conference on Malignant Lymphoma: Management of ?ultra-high-risk? Patients

ESMO Consensus Conference on Malignant Lymphoma: Management of ?ultra-high-risk? Patients SPECIAL ARTICLE ESMO Consensus Conference on malignant lymphoma: management of ‘ultra-high-risk’ patients M. Hutchings 1 * , M. Ladetto 2 , C. Buske 3 , P. de Nully Brown 1 , A. J. M. Ferreri 4 , M. Pfreundschuh 5† , N. Schmitz 6 , A. Sureda Balari 7 , G. van Imhoff 8 , J. Walewski 9 & the ESMO Lymphoma Consensus Conference Panel Members ‡ 1 Department of Hematology, Rigshospitalet, Copenhagen, Denmark; 2 (...) poorly to therapy and eventually die from their disease. A number of clinical and pathological factors de?ne groups of patients who are at very high risk of such treatment failure. For these ‘ultra-high-risk’ patients, there is no international consensus regarding the opti- mal management approach. In 2015, the European Society for Medical Oncology (ESMO) held a consensus conference on malignant lymphoma in order to develop recommendations on critical subjects that were dif?cult to consider in detail

2018 European Society for Medical Oncology

37. Shared follow-up and survivorship care for women with low-risk endometrial cancer Guidance Toolkit

a range of health settings and conditions including diabetes, paediatric oncology and obstetric care. It involves active participation from both the primary care and specialist teams to help plan and manage patient care. 2 This guidance toolkit is relevant for anyone involved in shared follow- up and survivorship care for women with low-risk endometrial cancer. In particular, it can be used by healthcare professionals as a general guide to appropriate practice when managing shared follow-up (...) to foster quality cancer care from diagnosis. National Framework for Gynaecological Cancer Control outlines future directions in national gynaecological cancer control to improve outcomes for women affected by gynaecological cancers. Follow-up care for women with low-risk endometrial cancer: A guide for General Practitioners provides guidance for GPs in managing aspects of follow-up and survivorship care for women following completion of active treatment for low-risk endometrial cancer. Roles

2020 Cancer Australia

38. Tinnitus: assessment and management

Tinnitus: assessment and management Tinnitus: assessment and management NICE guideline Published: 11 March 2020 www.nice.org.uk/guidance/ng155 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals (...) mental health management team for assessment people who have tinnitus associated with a high risk of suicide. If needed, provide a safe place while waiting for the assessment. 1.2.2 Refer immediately, in line with the NICE guideline on suspected neurological conditions, people with tinnitus associated with: • sudden onset of significant neurological symptoms or signs (for example, facial weakness), or or • acute uncontrolled vestibular symptoms (for example, vertigo), or or • suspected stroke (follow

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

39. Acute kidney injury: prevention, detection and management

at increased risk of contrast-induced acute kidney injury. The committee agreed that more research on estimating the risk of contrast-induced acute kidney Acute kidney injury: prevention, detection and management (NG148) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 21 of 26injury would help to inform future guidance, so made a research recommendation on the use of eGFR thresholds to stratify risk. Although the committee (...) Acute kidney injury: prevention, detection and management Acute kidney injury: prevention, detection and management NICE guideline Published: 18 December 2019 www.nice.org.uk/guidance/ng148 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

40. COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community

COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community NICE guideline Published: 3 April 2020 www.nice.org.uk/guidance/ng165 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE (...) ://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 14Contents Contents Overview 4 1 Communicating with patients and minimising infection risk 6 2 Treatment and care planning 8 3 Diagnosis and assessment 9 Diagnosing pneumonia 9 Assessing severity 9 Differentiating viral COVID-19 pneumonia from bacterial pneumonia 10 4 Managing suspected or confirmed pneumonia 12 Deciding about hospital admission 12 Managing breathlessness 12 Antibiotic treatment 13 Oral corticosteroids 14 Safety netting

2020 National Institute for Health and Clinical Excellence - Clinical Guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>